Showing results (3851-3860 of 8,680) with videos related to

Sort By:
Pageof 868
Bioorganic Chemistry|December 8, 2023
New resveratrol analogs as improved biologically active structures: Design, synthesis and computational modelingMilena Mlakić, Ilijana Odak, Danijela Barić, et al.
Bioorganic Chemistry|December 6, 2023
Molecular hybrids of substituted phenylcarbamoylpiperidine and 1,2,4-triazole methylacetamide as potent 15-LOX inhibitors: Design, synthesis, DFT calculations and molecular docking studiesZahid Nawaz, Naheed Riaz, Muhammad Saleem, et al.
Bioorganic Chemistry|January 9, 2024
Decaging-to-labeling: Development and investigation of quinone methide warhead for protein labelingFuhu Guo, Shengnan Qin, Ziqi Liu, et al.
Bioorganic Chemistry|January 4, 2024
A comprehensive review of small molecules targeting PI3K pathway: Exploring the structural development for the treatment of breast cancerRahul Dubey, Anushka Sharma, Shankar Gupta, et al.
Bioorganic Chemistry|January 1, 2024
Near-infrared light controlled protein degradation by photo-caged lenalidomide and pomalidomideYaoji Zhu, Xiaosa Yan, Yinan Shi, et al.
Bioorganic Chemistry|December 27, 2023
Threose nucleic acid as a primitive genetic polymer and a contemporary molecular toolJuan Wang, Hanyang Yu
Bioorganic Chemistry|December 30, 2023
Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitorYaoliang Sun, Zhiwen Chen, Guobin Liu, et al.
Bioorganic Chemistry|December 30, 2023
Design, synthesis, molecular docking and biological evaluation of 1,3,5-trisubstituted-1H-pyrazole derivatives as anticancer agents with cell cycle arrest, ERK and RIPK3- kinase activitiesNader M Boshta, Ahmed Temirak, Zeinab A El-Shahid, et al.
Bioorganic Chemistry|December 23, 2023
Synthesis and biological evaluation of 2'-hydroxychalcone derivatives as AMPK activatorsDuy Vu Nguyen, Chatchai Muanprasat, Suchada Kaewin, et al.
Bioorganic Chemistry|December 14, 2023
Design, synthesis, and biological evaluation of N-(pyridin-3-yl)pyrimidin-4-amine analogues as novel cyclin-dependent kinase 2 inhibitors for cancer therapyWen-Bin Zeng, Tang-Yang Ji, Yan-Ting Zhang, et al.
Pageof 868